Page 1, 2, 3
Notes
1. Second Opinion [website]. www.secondopinionnewsletter.com.
2. Biesel. JAMA. 1981.
3. Yim H et al. J Biol Chem. 1995;270:2828-2833.
4. Jouven X, Charles MA, et al. Circulation. 2001 Aug 14;104(7):756-761.
5. Holman et al. Physiol Rev 87:1175-1213.
6. J Nutr. Biochem. 2002;13.
7. Chien et al. J Food Drug Anal. 2008;8(1):1-15.
8. USDA National Agricultural Library. [online document] www.nal.usda.gov/fnic/foodcomp/Data/retn5/retn_tbl.pdf.
9. Ross J. The Diet Cure. Rev ed. Viking-Penguin; 2012.
10. Ross J. The Mood Cure. Viking-Penguin; 2004.
11. Lustgig R et al. Is sugar toxic (and addictive)? Nature. February 2012.
12. Fortuna J. J Psychoactive Drugs. 2012.
13. Stice E. Neuroimage. 2012
14. Cottone P. Neuropyschopharmacology. 2012.
15. Audhya T. Advances in measurement of platelet catecholamines at sub-picomole level for diagnosis of depression and anxiety. Clin Chem. 2005;1151(6 Suppl).
16. Mokdad AH et al. Epidemics of obesity and diabetes in USA. JAMA. 2001 Sept. 12.
17. Trayhurn P, Beattie JH. Physiological role of adipose tissue:white adipose tissue as an endocrine and secretory organ. Nutr Soc. 2001;60:329-339.
18. Bank WA et al.Triglycerides induce leptin resistance at the blood-brain barrier. Diabetes. 2004 May;53(5):1258-1260.
19. Huo L, Munzberg H, et al. Role of signal transducer and activator of transcription 3 in regulation of hypothalamic trh gene extression by leptin. Endocrinology 2004 May;145(5):2516-2523.
20. Travison TG et al. J Clin Endocrinol Metab. 2007 Jan;92(1):196-202.
21. Mulligan T et al. Int J Clin Prac. 2006 Jul;60(7):762-769.
22. Kupelia Y et al. J Clin Endocrinol Metab. 2006;91:843-50.
23. Laaksonen DE et al. Diabetes Care. 2004:27(5):1036-1104.
24. Laughlin G et al. EDNO 2007 Abstract OR55-2.
25. Longcope C. Methods & results of aromatization studies in vivo. Cancer Res. 1982;42:3307S-3311S.
26. Schneider G. J Clin Endocrinol Metab. 1979;48:633-638.
27. Cherdshewasart E. Nimsakul N. Clinical trial of Butea superba, an alternative herbal treatment for erectile dysfunction. Asian J Androl. 2003 Sep;5(3):243-246.
28. Talbott S et al. J Int Soc Sports Nutr. 2006;3(1):S1-S29.
29. Hamzah S, Yusof A. Br J Sports Med. 37:464-470.
30. Scorei RI et al. Boron containing compounds as preventive and chemotherapeutic agents for cancer. Anticancer Agents Med Chem. May 2010.
31. Om AS et al. Dietary zinc deficiency alters 5 alpha-reduction and aromatization of testosterone and androgen and estrogen receptors in rat liver. Nutr. 126(4):842-848.
32. Telang NT et al. Inhibition of proliferation and modulation and estradiol metabolism:novel mechanisms for breast cancer prevention by the phytochemical I3C. Proc Soc Exp Biol Med. 1997;216:246-52.
33. Smith S, Sepkovic D, Bradlow HL, Auborn KJ. 3,3 - Diindolymethane and genistein decreases the adverse effects of estrogen in LNCaP & PC-3 prostate cancer cells. J Nutr. 2008 Dec;138(12):2379-2385.
34. Lo R, Matthews J. A new class of estrogen receptor beta-selective activators. Mol Interv. 2010 Jun;10(3):133-136.
35. Stettner M et al. Mol Cancer Ther. Epub 2007.
36. Collins JK, Wu G, Perkins-Veazie P, Spears K, Claypool PL, Baker RA, Clevidence BA. Nutrition. 2007 March.
37. US Department of Health and Human Services. http://www.hhs.gov. Accessed June 2008.
38. Carter, J Lippa CF. Beta-amyloid, neuronal death and Alzheimer's disease. Curr Mol Med. 2001;1(6):733-737.
39. McGeer Eg, McGeer PL. Innate immunity in Alzheimer's disease:a model for local inflammatory reactions. Mol Interventions. 2001;1:22-29.
40. Pitchumoni SS, Coraiswamy PM.Current status of antioxidant therapy for Alzheimer's disease. J Am Geriatr Soc. 1996;46:1566-1572.
41. Roberts E. Pregnenolone from Selye to Alzheimer's. Bio Chem Pharma. 1995;49(1):1-16.
42. Veiga S, Garcia-Segura, Neuroprotection by the steroids Pregnenolone and dehydroepiandrosterone is mediated by the enzyme aromatase. J Neurobiol. 2003 Sep 15;56.
43. Mayo W, Le Moal M. Pregnenolone sulfate and aging of cognitive functions:behavioral neurochemical, morphological investigations. Horm Behav. 2001 Sep;40(2):215-217.
44. Vallee M, Purdy RH. Neuroactive steroids:new biomarkers of cognitive aging. J Steriod Biochem Mol Biol. 2003 Jun;85(2-5):329-332.
45. Damaudery M, Koehl M, Pallares M, Le Moal, MJ, Mary W. The neurosteriod pregnenolone sulfate increases cortical acetyl-choline release:A microdialysis study of freely moving rats. J Neurochem. 1998 Nov;71(5):2018-2022.
46. Pincus G, Hoagland H. Effects of administered Pregnenolone on fatiguing psychomotor performance. Aviation Med. April 1944:98-115.
47. Mayo W. Le Moal M. Pregnenolone sulfate and aging of cognitive functions: behavioral, neurochemical, morphological investigations. Horm Behav. 2001 Sep; 40(2): 215-217.
48. Damaudery M, Koehl M, Pallares M, Le Moal MJ, May W. The neurosteriod Pregnenolone sulfate increases cortical acetylcholine release: A microdialysis study of freely moving rats. J Neurochem. 1998 Nov;71(5):2018-2022.
49. Veiga S. Garcia-Segurea. Neuroprotection by the steroids Pregnenolone and dehydroepiandrosterone is mediated by the enzyme aromatase. J Neurobiol. 2003 Sep 15;66(4):398-406.
50. Kidd PM. PS (Phosphatidylserine). Natures Brain Booster for Memory, Mood, and Stress. St. George, UT: Total Health Communications; 2005.
51. Amenta F, Bronzetti E, Mancini M, et al. Choline acetyltransferase and acetylcholinesterase in the hippocampus of aged rats: sensitivity to choline alphoscerate treatment. Mechs Ageing Dev. 1994;74:47-58.
52. DeJesus Moreno Moreno M. Cognitive improvement in mild to moderate Alzheimer's dementia after treatment with the acetylcholine precursor choline alfoscerate, a multi center, double-blind, randomized, placebo-controlled trial. Clin Ther. 2002;25:178-193.
Page 1, 2, 3 |
